Find Your Funding Opportunity
NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
08-19-2025 | $37.7 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 30
- Opportunity Type Discretionary
-
CFDA
93.310 -- Trans-NIH Research Support
Description
The Office of Strategic Coordination (Common Fund) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for theNIH Director’s New Innovator Award, part of theHigh-Risk, High-Reward Research program. TheNIH Director’s New Innovator Awardsupports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Preliminary data and detailed experimental plans are not requested or required.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful and responsive projects. Investigators of exceptional creativity with a high-risk, high-impact proposal are encouraged to begin to consider applying for this new NOFO.This NOFO will utilize the DP2 (Clinical Trials Optional) activity code.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
U.S. Territory or Possession, Regional Organization,Eligible Agencies of the Federal Government. Applicants must be an Early Stage Investigator, as defined by NIH. Only single PD/PI applications allowed.
Key Date(s)
- May 12, 2025: Last Updated Date
- May 12, 2025: Forecasted Date
- June 19, 2025: Estimated Post Date
- August 19, 2025: Estimated Application Due Date
- September 21, 2026: Estimated Award Date
- September 28, 2026: Estimated Project Start Date